ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch [Yahoo! Finance]
Zenas BioPharma, Inc. (ZBIO)
Company Research
Source: Yahoo! Finance
BioPharma (NASDAQ:ZBIO) , an estimated $5.19 million trade based on quarterly average pricing. ENAVATE Sciences added 157,800 shares of Zenas BioPharma, an estimated $5.19 million trade based on quarterly average pricing. The quarter-end value of the Zenas BioPharma position increased by approximately $58.80 million, reflecting both the share purchase and stock price movement during the quarter. The transaction represented a 1.02% change relative to ENAVATE's $506.78 million in 13F reportable AUM. After the trade, ENAVATE held 3,919,159 shares of Zenas BioPharma valued at $142.30 million at quarter-end. Zenas BioPharma now accounts for 28.08% of ENAVATE's reportable AUM, making it the fund's largest holding. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, ENAVATE Sciences GP, LLC increased its holding in Zenas BioPharma by 157,800 shares during the quarter. The estimated transaction value is approximately $5.19 millio
Show less
Read more
Impact Snapshot
Event Time:
ZBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBIO alerts
High impacting Zenas BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
ZBIO
News
- Zenas BioPharma (ZBIO) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ZBIO&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" MarketBeat
- Zenas BioPharma (ZBIO) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Zenas BioPharma (ZBIO) had its price target lowered by Citigroup Inc. from $43.00 to $41.00. They now have a "buy" rating on the stock.MarketBeat
- Zenas BioPharma (ZBIO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $44.00 price target on the stock.MarketBeat
- Zenas BioPharma (ZBIO) had its price target raised by Morgan Stanley from $19.00 to $21.00. They now have an "equal weight" rating on the stock.MarketBeat
ZBIO
Earnings
- 3/16/26 - Miss
ZBIO
Sec Filings
- 3/16/26 - Form DEFA14A
- 3/16/26 - Form ARS
- 3/16/26 - Form DEF
- ZBIO's page on the SEC website